ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,852Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 223

$822K Total Retail Price of All Prescriptions

Rank: 15 out of 223

655 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Utah
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,859 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Utah
OMEPRAZOLE 708 620 1 3
LEVOTHYROXINE SODIUM 572 524 2 2
HYDROCODONE-ACETAMINOPHEN 572 475 S3 2 5
ZOLPIDEM TARTRATE 523 468 4 8
SIMVASTATIN 495 458 5 1
PRAVASTATIN SODIUM 441 427 6 15
METFORMIN HCL 296 265 7 7
GABAPENTIN 280 229 8 10
ALENDRONATE SODIUM 273 252 9 19
POTASSIUM CHLORIDE 249 209 10 12
FUROSEMIDE 248 232 11 9
CITALOPRAM HBR 245 232 12 16
LISINOPRIL 243 225 13 4
WARFARIN SODIUM 242 232 14 11
GLIMEPIRIDE 242 201 14 30
MELOXICAM 236 211 16 33
FENOFIBRATE 227 201 17 38
ATORVASTATIN CALCIUM 174 145 18 17
AMLODIPINE BESYLATE 158 146 19 6
TRIAMTERENE-HCTZ 157 144 20 39
FLUOXETINE HCL 155 105 21 24
CELEBREX 147 134 22 42
CARVEDILOL 142 131 23 23
ALLOPURINOL 137 135 24 28
TRIAMTERENE-HYDROCHLOROTHIAZID 129 115 25 119
ACTOS 129 128 25 95
METFORMIN HCL ER 121 94 27 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 113 109 28 29
DIGOXIN 107 95 29 73
SYNTHROID 102 101 30 35
TAMSULOSIN HCL 101 93 31 26
METOPROLOL SUCCINATE 99 82 32 20
LOSARTAN POTASSIUM 97 97 33 14
PREDNISONE 93 90 34 43
AZITHROMYCIN 92 73 35 44
TRAMADOL HCL 89 56 36 18
CYMBALTA 86 63 37 40
ADVAIR DISKUS 82 81 38 47
LANOXIN 81 65 39 183
CIPROFLOXACIN HCL 79 69 40 53
HYDROCHLOROTHIAZIDE 78 68 41 13
LOSARTAN-HYDROCHLOROTHIAZIDE 76 76 42 31
CARBIDOPA-LEVODOPA 76 44 42 101
ZETIA 73 72 44 68
LANTUS 71 52 45 34
SERTRALINE HCL 71 66 45 21
PANTOPRAZOLE SODIUM 69 61 47 45
COUMADIN 69 69 47 216
FLUTICASONE PROPIONATE 68 53 49 27
POLYETHYLENE GLYCOL 3350 68 44 49 69
PAROXETINE HCL 66 33 51 52
FINASTERIDE 66 64 51 58
NAPROXEN 65 12 53 80
DIOVAN 64 48 54 54
NAMENDA 56 56 55 48
PIOGLITAZONE HCL 56 56 R 55 239
PHENYTOIN SODIUM EXTENDED 55 36 57 187
MORPHINE SULFATE ER 54 26 S2 58 90
DIOVAN HCT 54 46 58 111
ACTOPLUS MET 54 43 58 247
BUPROPION HCL SR 52 31 61 72
CLOPIDOGREL 51 51 62 56
ISOSORBIDE MONONITRATE ER 50 50 63 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.